The Vitamin Shoppe launched its first proprietary CBD hemp extract products under its Full Spectrum plnt and Broad Spectrum Vthrive The Vitamin Shoppe Brands, marking the retailer’s continued expansion of its private brands portfolio in the CBD category....
As the excitement over CBD levels out, many are turning their attention to CBN. The minor cannabinoid is especially appealing to many tired Americans, as it makes name for itself as a sedative.
Proposed rules regulating the sale of ingestible products containing hemp-derived cannabinoids in New York have been hailed as “pragmatic” and “rational” by brands attempting to navigate the regulatory minefield in the absence of federal regulations.
Has Covid-19 affected your business (positively and/or negatively)? Are you changing how you think about the supply chain? And which health categories are the big winners and losers in 2020?
The Senate passed a continuing resolution Wednesday that provides short term funding in a move that will prevent a government shutdown. The resolution also included the House’s language to extend the hemp pilot program through September of 2021.
A new extraction facility is about to come online in Florida, while at the same time a California company is planning a launch of CBD products in Brazil and Uruguay.
This month, Martha Stewart ditched the fancy desserts for gourmet gummies, seasonal probiotics for the whole family are now available and cacao fruit headlines a new wellness line.
GW Pharmaceuticals and supplement retailer GNC have reportedly been among the companies meeting recently with a White House division to discuss aspects of CBD regulation.
As the weather cools down and we get back into routines, brands are launching products that offer sleep and immune support and even candy flavored protein to get consumers into the Halloween spirit.
It was hard enough keeping everyone on the same compliance page and then along came COVID-19. During the pandemic, FDA has published dozens of guidance documents for the dietary supplement industry as well as other stakeholders.
The US Food and Drug Administration has announced a virtual public meeting to explore the potential sex (biological) and gender (psychosocial) differences in use and responses to cannabidiol (CBD) and other cannabinoids.
